TABLE 1.
G. vaginalis strain characteristicsa
| Strain | Clade (29)/subgroup (30)/sequence variant (9) | Genome size (kb) | GC content (%) | MIC (μg/mL) |
|||
|---|---|---|---|---|---|---|---|
| Clindamycin | Erythromycin | Metronidazole | Tinidazole | ||||
| NCTC 10287 | 1/C/G2 | 1,663 | 41.3 | 0.015625 | 0.015625 | 4 | 2–4 |
| NCTC 10915 | 1/C/G2 | 1,665 | 41.2 | 0.03125 | 0.015625 | 4 | 2 |
| NCTC 11292 | 1/C/G2 | 1,659 | 41.3 | 0.03125 | 0.015625 | 4 | 2–4 |
| KC1 | 3/D/G1 | 1,542 | 43.3 | 0.015625 | 0.015625 | >256 | 128 |
| KC2 | 1/C/G2 | 1,657 | 41.3 | 0.0625 | 0.015625 | 2 | 1–8 |
| KC3 | 1/C/G2 | 1,733 | 41.1 | 0.0625 | 0.03125 | 16 | 64−128 |
| KC4 | 1/C/G2 | 1,660 | 41.3 | ng | 0.0078125 | 4 | ng |
a
All strains are positive for the genes encoding sialidase and vaginolysin. Concordant MICs are reported from three independently repeated experiments. ng, no growth.